Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Lilli-Marie Mendel"'
Autor:
Alexandra Reiter, Susanne A. Bengesser, Anne-Christin Hauschild, Anna-Maria Birkl-Töglhofer, Frederike T. Fellendorf, Martina Platzer, Tanja Färber, Matthias Seidl, Lilli-Marie Mendel, Renate Unterweger, Melanie Lenger, Sabrina Mörkl, Nina Dalkner, Armin Birner, Robert Queissner, Carlo Hamm, Alexander Maget, Rene Pilz, Alexandra Kohlhammer-Dohr, Jolana Wagner-Skacel, Kathrin Kreuzer, Helmut Schöggl, Daniela Amberger-Otti, Theresa Lahousen, Birgitta Leitner-Afschar, Johannes Haybäck, Hans-Peter Kapfhammer, Eva Reininghaus
Publikováno v:
Nutrients, Vol 12, Iss 9, p 2575 (2020)
Major depressive disorder (MDD) is a prevalent disease, in which one third of sufferers do not respond to antidepressants. Probiotics have the potential to be well-tolerated and cost-efficient treatment options. However, the molecular pathways of the
Externí odkaz:
https://doaj.org/article/d8443714cf464efe8e49555445fc9860
Autor:
Kathrin Kreuzer, Alexandra Reiter, Anna Birkl-Töglhofer, Nina Dalkner, Sabrina Mörkl, Marco Mairinger, Eva Fleischmann, Frederike Fellendorf, Martina Platzer, Melanie Lenger, Tanja Färber, Matthias Seidl, Armin Birner, Robert Queissner, Lilli-Marie Mendel, Alexander Maget, Alexandra Kohlhammer-Dohr, Alfred Häussl, Jolana Wagner-Skacel, Helmut Schöggl, Daniela Amberger-Otti, Annamaria Painold, Theresa Lahousen-Luxenberger, Brigitta Leitner-Afschar, Johannes Haybaeck, Hansjörg Habisch, Tobias Madl, Eva Reininghaus, Susanne Bengesser
Publikováno v:
Metabolites; Volume 12; Issue 8; Pages: 770
The gut–brain axis plays a role in major depressive disorder (MDD). Gut-bacterial metabolites are suspected to reduce low-grade inflammation and influence brain function. Nevertheless, randomized, placebo-controlled probiotic intervention studies i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1851beee255bed6e0852e35bdd04172
Autor:
Frederike T. Fellendorf, Renate Unterweger, Nina Dalkner, Johannes Haybäck, Sabrina Mörkl, Eva Z. Reininghaus, Birgitta Leitner-Afschar, Matthias Seidl, Anne-Christin Hauschild, Martina Platzer, Robert Queissner, Armin Birner, Theresa Lahousen, Alexander Maget, Melanie Lenger, Alexandra Kohlhammer-Dohr, Susanne Bengesser, Helmut Schöggl, Jolana Wagner-Skacel, Carlo Hamm, Rene Pilz, Alexandra Reiter, Hans-Peter Kapfhammer, Anna-Maria Birkl-Töglhofer, Tanja Färber, Daniela Amberger-Otti, Lilli-Marie Mendel, Kathrin Kreuzer
Publikováno v:
Nutrients
Volume 12
Issue 9
Nutrients, Vol 12, Iss 2575, p 2575 (2020)
Volume 12
Issue 9
Nutrients, Vol 12, Iss 2575, p 2575 (2020)
Major depressive disorder (MDD) is a prevalent disease, in which one third of sufferers do not respond to antidepressants. Probiotics have the potential to be well-tolerated and cost-efficient treatment options. However, the molecular pathways of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed6c566ac87e4af4946b386f9e53e728